| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |